 |
 |
| |
|
|
| |
Recent developments and changes which include breakthroughs in digital health, the emergence and growth of novel therapies, the rise of customized care, and value-based care are remodeling health care. To keep up with the changes in the post-pandemic world, healthcare leaders need to reimagine their strategies, value propositions, and organizational capabilities. Such changes will help substantially and sustainably improve patient care and open new opportunities for players across the healthcare and life sciences market landscape.
Acuity Life Sciences and Healthcare collate and provide for the most recent developments in healthcare and life sciences that may significantly impact the industry. Enjoy reading.
Manish Chandna – Director and Global Head, Consulting and Corporates
|
|
| |
|
|
|
Fresh and unique: Hand-picked content carefully curated for you
|
|
| |
|
|
|
|
Portfolio remodeling by pharma companies: Strategies for sustainable growth |
|
Exploring advancement in genomics in Saudi Arabia – a study of the market landscape
|
 |
|
 |
|
|
|
The blog focuses on how pharma companies are remodeling their portfolios to cater to this new market and its demands.
|
|
This blog focuses on understanding the applications, growth drivers, regulatory, and competitive landscape of the genomics market in KSA.
|
|
|
|
|
|
| |
|
|
|
|
The USFDA has approved BioMarin's Roctavian, the first and only gene therapy medication of its kind for persons with severe haemophilia A. |
|
Genesis Therapeutics has successfully raised an investment of $200 Mn
|
 |
|
 |
|
|
|
Roctavian is a type of gene therapy given that is a single-dose infusion and is the first approved gene therapy for severe hemophilia A. This new treatment is indicated for hemophilia A and helps control bleeding.
|
|
Genesis Therapeutics, a company that focuses on using artificial intelligence (AI) to develop new medicines for people with severe illnesses, announced today that it has successfully raised $200 million in a Series B funding round.
|
|
|
|
|
| |
|
|
|
|
|
|
NICE announces launch of digital and AI advice service for healthcare sector |
|
Argenta and Prelude collaborated to offer animal health industry top-notch data management software and assistance.
|
 |
|
 |
|
|
|
The National Institute for Health and Care Excellence (NICE) has announced the launch of a new online advisory service to help the NHS and wider healthcare system use new digital technologies and artificial intelligence (AI).
|
|
Through this collaboration, Argenta will gain access to the complete range of Prelude's data management solutions, along with enhanced technical assistance and training for new products and functionalities.
|
|
|
|
|
| |
|
|
|
|
|
Services offered by Acuity
|
|
| |
|
|
|
|
Healthcare Market Intelligence |
|
Pharma Market Intelligence
|
 |
|
 |
|
|
|
Acuity’s healthcare market intelligence programmes enable healthcare innovators to do so with actionable technical and commercial insights based on scientific proof and opinions of key leaders.
Acuity provides healthcare consulting services and healthcare competitive intelligence from the perspective of healthcare professionals, covering products and services that support healthcare workers and administrators.
|
|
Acuity’s team of subject-matter experts and significant expertise in strategic research and analysis, along with deep sector knowledge, have helped global pharma consulting and corporate clients implement tactical projects.
Acuity conducts specialized research within the pharma space and support clients in areas such as clinical trial analysis, competitive benchmarking, pharma market intelligence, pipeline analysis, mergers and acquisitions, due diligence, strategic analysis, pharma market research, pharmaceutical competitive intelligence, pharma forecasting, sales by indication, drug launch, opportunity assessment and go-to-market strategic projects.
|
|
|
|
|
|
| |
|
|
| |
How Acuity Knowledge Partners can help
|
|
| |
|
|
| |
Acuity Knowledge Partners (Acuity) is a leading provider of high-value research, analytics and business intelligence services to life sciences, biopharma, MedTech and healthcare consulting firms. We provide bespoke research support on market entry and due diligence, portfolio management, licensing and acquisition, go-to-market strategy, opportunity assessment, regulatory landscaping, product launch analysis, market access and therapy area assessment, indication prioritization, market research and forecasting, pipeline analysis and benchmarking and competitive intelligence.
|
|
| | | |
| |
| | |
| | |
ABOUT ACUITY KNOWLEDGE PARTNERS
Acuity Knowledge Partners (Acuity) is a leading provider of bespoke research, analytics and technology solutions to the financial services sector, including asset managers, corporate and investment banks, private equity and venture capital firms, hedge funds and consulting firms. Its global network of over 6,000 analysts and industry experts, combined with proprietary technology, supports more than 500 financial institutions and consulting companies to operate more efficiently and unlock their human capital, driving revenue higher and transforming operations. Acuity is headquartered in London and operates from 10 locations worldwide.
Acuity was established as a separate business from Moody’s Corporation in 2019, following its acquisition by Equistone Partners Europe (Equistone). In January 2023, funds advised by global private equity firm Permira acquired a majority stake in the business from Equistone, which remains invested as a minority shareholder.
For more information, visit www.acuitykp.com
|
|
| | | | | | US: +1 929 618 0217 | UK: +44 20 7550 4499 | India: +91 80 6113 3000
Sri Lanka: +94 11 235 6000 | Beijing: +86 10 8248 6812 | HK: +852 (972) 836-39 | contact@acuitykp.com | |
| | | |
| | | | | | ©2023 Acuity Knowledge Partners. All rights reserved. | |
| | | |
| |